Meds & supplements › Glatiramer
Medicine
Glatopa is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
WARNING: ANAPHYLACTIC REACTIONS Cases of life-threatening and fatal anaphylaxis have been reported with glatiramer acetate injection. Anaphylaxis can occur at any time following initiation of therapy, from as early as after the first dose, up to years following initiation of therapy. • Make patients aware of the symptoms of anaphylaxis, which may overlap with those of an immediate post-injection reaction; instruct them to seek immediate medical care should these symptoms occur. Prompt identification of anaphylaxis is important to avoid a delay in treatment. • Glatiramer acetate injection is contraindicated in patients with a history of hypersensitivity reactions to glatiramer acetate injection, including anaphylaxis. If an anaphylactic reaction occurs, treatment with glatiramer acetate injection must be immediately discontinued. Unless a clear alternative etiology is identified, glatiramer acetate injection must be permanently discontinued. WARNING: ANAPHYLACTIC REACTIONS See full prescribing information for complete boxed warning. Life-threatening and fatal anaphylaxis, which can occur at any time following initiation of therapy (from as early as after the first dose, up to years after initiation of treatment), has been reported in patients receiving glatiramer acetate injection. • Make patients aware of the symptoms of anaphylaxis, which may overlap with those of an immediate post-injection reaction.
Glatopa is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatopa is indicated for the treatment of relapsing-forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Serious allergic reactions (anaphylactic reactions). Serious allergic reactions that may be life-threatening or lead to death may happen any time after you start using glatiramer acetate injection. These reactions may happen right after your first dose up to years after starting treatment with glatiramer acetate injection, even if you never had an allergic reaction before.
Many reactions have happened within 1 hour of using glatiramer acetate injection. Some signs and symptoms may be the same as those of an immediate post-injection reaction. See
Stop using glatiramer acetate injection and get emergency help right away if you have: o widespread rash o swelling of the face, eyelids, lips, mouth, throat, or tongue o sudden shortness of breath, difficulty breathing, or wheezing o uncontrolled shaking (convulsions) o trouble swallowing or speaking o fainting, feeling dizzy or faint What is glatiramer acetate injection?
Glatiramer acetate injection is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is not known if glatiramer acetate injection is safe and effective in children under 18 years of age.
Do not take glatiramer acetate injection: if you are allergic to glatiramer acetate or mannitol. Serious allergic reactions including life-threatening or anaphylactic reactions that can lead to death have happened. See the end of this leaflet for a complete list of the ingredients in glatiramer acetate injection. Before you use glatiramer acetate injection, tell your healthcare provider about all of your medical conditions, including if you: are pregnant or plan to become pregnant.
Talk to your healthcare provider who will advise if you should take glatiramer acetate injection during your pregnancy. are breastfeeding or plan to breastfeed. It is not known if glatiramer acetate passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while using glatiramer acetate injection.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Glatiramer acetate injection may affect the way other medicines work, and other medicines may affect how glatiramer acetate injection works. Know the medicines you take.
Keep a list of your medicines with you to show your healthcare provider and pharmacist when you get a new medicine. How should I use glatiramer acetate injection? For detailed instructions, see the Instructions for Use at the end of this leaflet for complete information on how to use glatiramer acetate injection. Your healthcare provider will tell you how much glatiramer acetate injection to use and when to use it.
Glatiramer acetate injection is given by injection under your skin (subcutaneously). Use glatiramer acetate injection exactly as your healthcare provider tells you to use it. Since every body type is different, talk with your healthcare provider about the injection areas that are best for you. You should receive your first dose of glatiramer acetate injection with a healthcare provider or nurse present.
This might be at your healthcare provider’s office or with a visiting home health nurse who will teach you how to give your glatiramer acetate injections. Some glatiramer acetate products can be used with an optional compatible autoinjector. Compatible autoinjectors are supplied separately if available, but the availability of compatible autoinjectors may change with time.
o Check with your healthcare provider when you fill or refill your medicine to make sure the autoinjector you have is meant to be used with your glatiramer acetate product. Not all optional autoinjectors are meant to be used with all glatiramer acetate products. If you use the wrong autoinjector, you might not get the correct dose of your medicine.
Contact the manufacturer of your glatiramer acetate product to find out if there is an autoinjector that is meant to be used with your glatiramer acetate product. Read your Instructions for Use and talk to your healthcare provider about the best way for you to use glatiramer acetate injection. What are the possible side effects of glatiramer acetate injection?
Glatiramer acetate injection may cause serious side effects, including: Immediate Post-Injection Reactions. Serious side effects may happen right after or within minutes after you inject glatiramer acetate injection at any time during your course of treatment. Some signs and symptoms may be the same as those of a serious allergic reaction (anaphylaxis).
Call a healthcare provider right away if you have any of these immediate post-injection reaction symptoms including: o redness to your cheeks or other parts of the body (flushing) o chest pain o fast heartbeat o anxiety o breathing problems or tightness in your throat o swelling, rash, hives, or itching If you have symptoms of an immediate post-injection reaction, do not give yourself more injections until a healthcare provider tells you to.
Chest Pain.
Store glatiramer acetate injection in the refrigerator between 2° to 8°C (36° to 46°F). When you are not able to refrigerate glatiramer acetate injection, you may store it for up to 1 month at room temperature between 15° to 30°C (59° to 86°F). Protect glatiramer acetate injection from light or high temperature. Do not freeze glatiramer acetate syringes.
If a syringe freezes, throw it away in a sharps disposal container. See Step 13 in the Instructions for Use, “Dispose of your needles and syringes”. Keep glatiramer acetate injection and all medicines out of the reach of children.
sofidex [Internet]. Daloreum; c2026. Glatiramer; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/glatiramer
sofidex. (2026, August 2). Glatiramer. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/glatiramer
Glatiramer. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/glatiramer
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.